Int. J. Mol. Sci. 2011, 12(6), 3846-3856; doi:10.3390/ijms12063846

Protective Role of α2HS-Glycoprotein in HBV-Associated Liver Failure

1email, 2email, 1email, 1email, 1email, 1email, 1email and 1,* email
Received: 25 April 2011; in revised form: 25 May 2011 / Accepted: 3 June 2011 / Published: 10 June 2011
(This article belongs to the Section Biochemistry, Molecular Biology and Biophysics)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: n this study, levels of plasma α2-Heremans-Schmid glycoprotein, serum tumor necrosis factor-α, serum liver function parameters and short-term mortality were measured in 100 hepatitis B patients. Release of interleukin-6 and tumor necrosis factor-α from the lipopolysaccharide-stimulated peripheral blood mononuclear cells in the presence/absence of spermine and α2-Heremans-Schmid glycoprotein were analyzed by enzyme-linked immunosorbent assay to determine the significance and potential mechanism of α2-Heremans-Schmid glycoprotein in hepatitis B virus-associated liver damage. Results showed that serum α2-Heremans-Schmid glycoprotein levels in acute-on-chronic liver failure patients were significantly lower than that in chronic hepatitis B patients or healthy controls (p < 0.05). A negative dependence between serum human α2-Heremans-Schmid glycoprotein and tumor necrosis factor-α levels was observed. Interleukin-6 and tumor necrosis factor-α levels in the lipopolysaccharide-induced peripheral blood mononuclear cell supernates were significantly reduced by spermine and/or α2-Heremans-Schmid glycoprotein. The latter two proteins jointly inhibited cytokine release. These observations suggest that plasma α2-Heremans-Schmid glycoprotein is an independent marker of liver damage and a prognostic indicator of hepatitis B virus chronicity. It may reduce liver inflammation by partially inhibiting release of inflammatory factors from activated peripheral blood mononuclear cells.
Keywords: human fetuin-a; α2-Heremans-Schmid glycoprotein; spermine; acute-on-chronic liver failure
PDF Full-text Download PDF Full-Text [218 KB, uploaded 19 June 2014 03:50 CEST]

Export to BibTeX |

MDPI and ACS Style

Dai, X.-H.; Zhang, P.; Xiao, M.-F.; Zhou, R.-R.; Zhang, B.-X.; Hu, G.-S.; Huang, Z.-B.; Fan, X.-G. Protective Role of α2HS-Glycoprotein in HBV-Associated Liver Failure. Int. J. Mol. Sci. 2011, 12, 3846-3856.

AMA Style

Dai X-H, Zhang P, Xiao M-F, Zhou R-R, Zhang B-X, Hu G-S, Huang Z-B, Fan X-G. Protective Role of α2HS-Glycoprotein in HBV-Associated Liver Failure. International Journal of Molecular Sciences. 2011; 12(6):3846-3856.

Chicago/Turabian Style

Dai, Xia-Hong; Zhang, Pan; Xiao, Mei-Fang; Zhou, Rong-Rong; Zhang, Bao-Xin; Hu, Guan-Sheng; Huang, Ze-Bing; Fan, Xue-Gong. 2011. "Protective Role of α2HS-Glycoprotein in HBV-Associated Liver Failure." Int. J. Mol. Sci. 12, no. 6: 3846-3856.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert